Department of Molecular Cell Mechanisms, Medical University of Lodz, Lodz, Poland.
Adv Exp Med Biol. 2020;1234:71-86. doi: 10.1007/978-3-030-37184-5_6.
Angiogenesis is a critical process required for tumor progression. Newly formed blood vessels provide nutrition and oxygen to the tumor contributing to its growth and development. However, endothelium also plays other functions that promote tumor metastasis. It is involved in intravasation, which allows invasive cancer cells to translocate into the blood vessel lumen. This phenomenon is an important stage for cancer metastasis. Besides direct association with cancer development, endothelial cells are one of the main sources of cancer-associated fibroblasts (CAFs). The heterogeneous group of CAFs is the main inductor of migration and invasion abilities of cancer cells. Therefore, the endothelium is also indirectly responsible for metastasis. Considering the above, the endothelium is one of the important targets of anticancer therapy. In the chapter, we will present mechanisms regulating endothelial function, dependent on cancer and cancer niche cells. We will focus on possibilities of suppressing pro-metastatic endothelial functions, applied in anti-cancer therapies.
血管生成是肿瘤进展所必需的关键过程。新形成的血管为肿瘤提供营养和氧气,促进其生长和发展。然而,内皮细胞也具有促进肿瘤转移的其他功能。它参与了血管内渗,使侵袭性癌细胞能够转移到血管腔中。这一现象是癌症转移的重要阶段。内皮细胞除了与癌症发展有直接关联外,还是癌症相关成纤维细胞(CAFs)的主要来源之一。CAFs 的异质性群体是诱导癌细胞迁移和侵袭能力的主要因素。因此,内皮细胞也间接地导致了转移。鉴于上述情况,内皮细胞是抗癌治疗的重要靶点之一。在这一章中,我们将介绍依赖于癌症和癌症微环境细胞的调节内皮功能的机制。我们将重点探讨抑制促转移内皮功能的可能性,将其应用于抗癌治疗。